By LINDA A. JOHNSON
TRENTON, N.J. (AP) Prescription-benefits manager Medco Health
Solutions Inc. has agreed to pay $155 million in fines to settle
fraud, kickback and other charges brought by federal prosecutors in
Philadelphia in a whistleblower case dating to 1999.
The agreement, announced Monday by Pat Meehan, U.S. attorney for
the Eastern District of Pennsylvania, involves multiple cases of
alleged wrongdoing by Medco, the nation's No. 2 pharmacy benefit
manager. The settlement comes nearly six months after the two sides
announced an agreement in principle shortly before a trial was to
begin.
``This settlement and others like it represent a sweeping change
in the way pharmacy benefit managers do business,'' Meehan said in
a statement, noting his office reached a $137 million settlement
last year with Medco's biggest competitor, Nashville, Tenn.-based
Caremark Rx Inc.
``Hidden financial agreements between PBMs and drug
manufacturers and health plans, along with the bottom-line
pressures of management, can influence which drugs patients
receive, the price we all pay for drugs and whether pharmacists
serve patients with their undivided professional judgment,'' Meehan
said.
Franklin Lakes-based Medco said in a statement that there was no
finding of wrongdoing by the company or any of its people, an
agreement typical in government prosecutions of corporations.
``Even though we did nothing wrong, for our company and our
clients it is the right decision to put these aged matters in the
past,'' Medco said in a statement.
Among other charges, Medco was accused of paying
health-insurance plans kickbacks to obtain their business and of
soliciting kickbacks from drug manufacturers to favor their drugs
over competitors' products, partly by illegally pressuring
pharmacists and doctors to switch prescriptions. Medco also was
accused of destroying patient prescriptions when its mail-order
pharmacies did not fill them as quickly as required by its
insurance plan contracts.
Those issues were brought to light by three whistleblowers,
Associate U.S. Attorney Jim Sheehan said in an interview. One of
them was a government informant and the other two were pharmacists
employed at Medco's Las Vegas pharmacy who told the government the
operation was poorly run, with prescriptions with the wrong number
of pills or other problems being shipped to customers anyway.
To settle those allegations, Medco will pay the government
$137.5 million, Sheehan said. Medco also must set up a strict
program to ensure it complies with all Medicare requirements and
pharmacy practice requirements, with both an independent reviewer
and the U.S. Attorney's Office reviewing its records annually for
five years, he said.
Meanwhile, Medco will pay an additional $9.5 million to settle
other civil charges in a case that Meehan's office expects to
announce soon, Sheehan said.
The remaining $8 million will cover a third case, Sheehan said,
involving a Medco program that helped its health plan clients get
reimbursed by Medicare for diabetes testing supplies used by
retired workers. Medco, which used a third-party contractor to run
that program, reported problems with it to the U.S. Attorney's
Office and ended the program, Sheehan said.
``What their contractor did was to create false documents to get
payment from Medicare,'' Sheehan said.
Medco announced the tentative settlement on May 5, when it
reported on its first-quarter profit. That quarter, Medco took a
charge of $163 million before taxes, or 32 cents per share, to
settle multiple federal legal cases.
The issues covered by the $163 million charge included inflating
the drug prices government health programs paid to Medco, the
company said at the time.
Medco handles prescription benefits for about 58 million
Americans, either by processing electronic claims from retail
pharmacies or by shipping medications directly from its dozen
mail-order pharmacies around the country.
In trading on the New York Stock Exchange Monday, Medco shares
rose 12 cents to $57.60.
^ =
On the Net: http://www.medco.com
(Copyright 2006 by The Associated Press. All Rights Reserved.)